Castle Biosciences market cap is $2 b, and annual revenue was $51.87 m in FY 2019

Castle Biosciences Gross profit (Q3, 2020)12.7 M

Castle Biosciences Gross profit margin (Q3, 2020), %83.7%

Castle Biosciences Net income (Q3, 2020)-4.6 M

Castle Biosciences EBIT (Q3, 2020)-3.9 M

Castle Biosciences Cash, 30-Sept-2020183.1 M

Castle Biosciences EV1.9 B

Castle Biosciences revenue was $51.87 m in FY, 2019 which is a 127.6% year over year increase from the previous period.

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Revenue | 13.8m | 22.8m | 51.9m |

| 66% | 128% | |

## Cost of goods sold | 4.9m | 5.3m | 7.3m |

## Gross profit | 8.8m | 17.5m | 44.6m |

| 64% | 77% | 86% |

## R&D expense | 4.5m | 4.9m | 7.4m |

## General and administrative expense | 15.3m | 16.5m | 29.8m |

## Operating expense total | 19.7m | 21.3m | 37.2m |

## EBIT | (10.9m) | (3.8m) | 7.3m |

| (79%) | (17%) | 14% |

## Interest expense | 1.6m | 2.3m | 4.6m |

## Interest income | 26.2k | 23.5k | 312.0k |

## Pre tax profit | (12.4m) | (6.4m) | 5.3m |

## Income tax expense | 9.7k | 8.6k | 72.0k |

## Net Income | (12.4m) | (6.4m) | 5.3m |

## EPS | (8.1) | (5.3) | (0.2) |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 3.7m | 4.0m | 3.7m | 8.7m | 10.7m | 14.8m | 17.4m | 12.7m | 15.2m |

## Cost of goods sold | 1.3m | 1.3m | 1.4m | 1.6m | 2.0m | 1.7m | 2.4m | 2.1m | 2.5m |

## Gross profit | 2.4m | 2.7m | 2.4m | 7.1m | 8.7m | 13.1m | 15.0m | 10.6m | 12.7m |

| 66% | 67% | 64% | 82% | 81% | 88% | 86% | 83% | 84% |

## R&D expense | 1.3m | 1.2m | 1.3m | 1.4m | 1.3m | 1.5m | 2.9m | 2.7m | 3.1m |

## General and administrative expense | 4.2m | 4.2m | 3.9m | 6.0m | 6.8m | 7.1m | 11.1m | 10.4m | 11.7m |

## Operating expense total | 5.5m | 5.3m | 5.2m | 7.4m | 8.1m | 8.6m | 14.0m | 13.1m | 16.6m |

## EBIT | (3.1m) | (2.7m) | (2.9m) | (322.0k) | 607.6k | 4.4m | 1.0m | (645.0k) | (3.9m) |

| (84%) | (67%) | (77%) | (4%) | 6% | 30% | 6% | (5%) | (26%) |

## Interest expense | 530.2k | 524.8k | 568.8k | 1.0m | 1.7m | 1.1m | 764.0k | 769.0k | 706.0k |

## Interest income | 5.4k | 2.2k | 13.3k | 21.0k | 5.5k | 5.2k | 298.0k | 38.0k | 18.0k |

## Pre tax profit | (3.6m) | (3.2m) | (3.5m) | (1.4m) | (1.3m) | 5.8m | 570.0k | (1.4m) | (4.6m) |

## Net Income | (3.6m) | (3.2m) | (3.5m) | (1.4m) | (1.3m) | 5.8m | 570.0k | (1.4m) | (4.6m) |

## EPS | (2.4) | (2.1) | (2.3) | (1.2) | (1.0) | 0.1 | 0.0 | (0.1) | (0.2) |

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Cash | 1.2m | 4.5m | 98.8m |

## Accounts Receivable | 4.7m | 12.1m | 14.6m |

## Prepaid Expenses | 515.5k | 675.6k | 2.0m |

## Inventories | 304.6k | 882.2k | 1.2m |

## Current Assets | 6.7m | 18.1m | 116.7m |

## PP&E | 1.5m | 1.5m | 2.1m |

## Total Assets | 9.8m | 22.4m | 119.7m |

## Accounts Payable | 1.1m | 1.5m | 1.9m |

## Short-term debt | 1.0m | 5.8m | |

## Current Liabilities | 5.2m | 6.7m | 15.3m |

## Long-term debt | 17.6m | 24.5m | 19.3m |

## Total Debt | 18.6m | 24.5m | 25.1m |

## Total Liabilities | 24.1m | 32.5m | 34.6m |

## Common Stock | 1.9k | 1.9k | 17.0k |

## Preferred Stock | 36.0m | 46.5m | |

## Additional Paid-in Capital | 809.2k | 921.4k | 137.3m |

## Retained Earnings | (51.1m) | (57.5m) | (52.2m) |

## Total Equity | (50.3m) | (56.6m) | 85.1m |

## Debt to Equity Ratio | -0.4 x | -0.4 x | 0.3 x |

## Debt to Assets Ratio | 1.9 x | 1.1 x | 0.2 x |

## Financial Leverage | -0.2 x | -0.4 x | 1.4 x |

USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|

## Cash | 16.2m | 17.5m | 94.5m | 98.7m | 179.8m | 183.1m |

## Accounts Receivable | 9.2m | 9.7m | 12.4m | 14.6m | 12.5m | 12.6m |

## Prepaid Expenses | 741.4k | 774.9k | 2.2m | 2.1m | 1.7m | 3.7m |

## Inventories | 809.3k | 550.9k | 821.7k | 1.2m | 1.7m | 1.7m |

## Current Assets | 27.0m | 28.5m | 109.9m | 116.6m | 195.7m | 201.1m |

## PP&E | 1.7m | 1.7m | 1.8m | 2.7m | 5.0m | 6.6m |

## Total Assets | 31.0m | 33.3m | 113.2m | 120.3m | 201.5m | 210.4m |

## Accounts Payable | 1.6m | 2.1m | 1.3m | 1.9m | 2.5m | 2.1m |

## Short-term debt | 3.6m | 5.3m | 3.3m | 8.3m | 10.0m | 10.0m |

## Current Liabilities | 9.0m | 11.7m | 9.2m | 15.3m | 28.2m | 30.2m |

## Long-term debt | 23.6m | 23.9m | 21.6m | 17.0m | 14.7m | 12.5m |

## Total Debt | 27.2m | 29.1m | 24.9m | 25.3m | 24.7m | 22.5m |

## Total Liabilities | 33.8m | 36.9m | 30.9m | 32.3m | 43.9m | 43.8m |

## Common Stock | 1.9k | 2.2k | 17.1k | 17.0k | 19.0k | 20.0k |

## Preferred Stock | 46.6m | |||||

## Additional Paid-in Capital | 9.4m | 9.9m | 136.6m | 139.6m | 210.6m | 224.1m |

## Retained Earnings | (58.8m) | (60.1m) | (54.3m) | (51.6m) | (53.0m) | (57.6m) |

## Total Equity | (49.4m) | (50.2m) | 82.3m | 87.9m | 157.6m | 166.6m |

## Debt to Equity Ratio | -0.6 x | -0.6 x | 0.3 x | 0.3 x | 0.2 x | 0.1 x |

## Debt to Assets Ratio | 0.9 x | 0.9 x | 0.2 x | 0.2 x | 0.1 x | 0.1 x |

## Financial Leverage | -0.6 x | -0.7 x | 1.4 x | 1.4 x | 1.3 x | 1.3 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Net Income | (12.4m) | (6.4m) | 5.3m |

## Depreciation and Amortization | 310.8k | 323.0k | 358.0k |

## Accounts Receivable | (428.2k) | (8.4m) | (896.0k) |

## Inventories | (115.6k) | (577.7k) | (355.0k) |

## Accounts Payable | 370.9k | 197.2k | 557.0k |

## Cash From Operating Activities | (12.2m) | (12.3m) | 7.0m |

## Purchases of PP&E | (494.9k) | (277.0k) | (937.0k) |

## Cash From Investing Activities | (494.9k) | (277.0k) | (937.0k) |

## Long-term Borrowings | (2.0m) | (1.8m) | |

## Cash From Financing Activities | 8.9m | 15.8m | 88.3m |

## Net Change in Cash | (3.9m) | 3.3m | 94.4m |

## Interest Paid | 1.1m | 1.6m | 2.2m |

## Income Taxes Paid | 159.7k |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (3.6m) | (6.8m) | (10.2m) | (1.4m) | (2.6m) | 3.2m | 570.0k | (806.0k) | (5.4m) |

## Depreciation and Amortization | 79.8k | 160.2k | 243.5k | 79.9k | 167.5k | 258.5k | 91.0k | 193.0k | 312.0k |

## Accounts Receivable | (38.0k) | (621.2k) | (655.2k) | 3.8m | 3.6m | 800.6k | 161.0k | 2.3m | 1.9m |

## Inventories | 97.0k | (101.7k) | (5.7k) | 72.9k | 331.3k | 60.6k | 19.0k | (430.0k) | (442.0k) |

## Accounts Payable | (217.2k) | (607.7k) | (170.9k) | (328.8k) | (524.0k) | (46.9k) | 56.0k | 444.0k | 211.0k |

## Cash From Operating Activities | (2.5m) | (7.2m) | (9.1m) | 1.3m | 1.8m | 2.5m | (251.0k) | 13.3m | 10.3m |

## Purchases of PP&E | (28.6k) | (184.6k) | (271.6k) | (243.6k) | (424.5k) | (589.7k) | (500.0k) | (2.3m) | (4.2m) |

## Cash From Investing Activities | (28.6k) | (184.6k) | (271.6k) | (243.6k) | (424.5k) | (589.7k) | (500.0k) | (2.3m) | (4.2m) |

## Long-term Borrowings | (989.1k) | (1.8m) | (1.8m) | (833.0k) | (3.3m) | ||||

## Cash From Financing Activities | 5.3m | 11.4m | 11.4m | 10.7m | 11.6m | 88.1m | 559.0k | 69.9m | 78.1m |

## Net Change in Cash | 2.8m | 4.0m | 2.1m | 11.8m | 13.0m | 90.0m | (192.0k) | 80.9m | 84.2m |

## Interest Paid | 453.5k | 791.5k | 1.2m | 572.4k | 1.1m | 1.7m | |||

## Income Taxes Paid | 159.4k |

USD | FY, 2017 |
---|---|

## Revenue/Employee | 215.5k |

## Debt/Equity | -0.4 x |

## Debt/Assets | 1.9 x |

## Financial Leverage | -0.2 x |